HGF-induced migration depends on the PI(3,4,5)P3-binding microexon-spliced variant of the Arf6 exchange factor

Colin D H Ratcliffe1,2, Nadeem Siddiqui1,2, Paula P Coelho1,2

  • 1Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.

Insights

Microexon skipping in cytohesin-1 controls cell migration by altering how it binds to cell membranes. This splicing mechanism spatially restricts signaling, linking receptor tyrosine kinases to Arf6 activity in cancer.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Alternative splicing, particularly microexon inclusion/skipping, is a key mechanism for generating protein diversity.
  • The functional roles of microexons and their impact on cellular signaling pathways remain largely unexplored.
  • Met receptor tyrosine kinase (RTK) signaling is crucial for regulating cell growth, invasion, and migration in both development and cancer.

Purpose of the Study:

  • To investigate the functional significance of microexon switching in cytohesin-1.
  • To elucidate the role of cytohesin-1 isoforms in Met-dependent cell migration.
  • To understand how microexon variations contribute to Arf6 signaling and phosphoinositide recognition.

Main Methods:

  • Analysis of cytohesin-1 isoforms generated by microexon inclusion/skipping.
  • Biochemical assays to determine phosphoinositide binding affinities (PI(4,5)P2 and PI(3,4,5)P3) of different cytohesin-1 variants.
  • Subcellular localization studies using microscopy to track isoform distribution within migrating cells.

Main Results:

  • Cytohesin-1 isoforms, differing by a three-nucleotide microexon, exhibit distinct affinities for PI(4,5)P2 (triglycine isoform) and PI(3,4,5)P3 (diglycine isoform).
  • The triglycine cytohesin-1 isoform preferentially localizes to the plasma membrane, while the diglycine isoform is enriched at the leading edge of migrating cells.
  • Microexon switching in cytohesin-1 directly influences Met-dependent cancer cell migration by modulating Arf6 activation.

Conclusions:

  • Microexon skipping in cytohesin-1 provides a mechanism for spatially regulating signaling pathways.
  • Differential phosphoinositide binding by cytohesin-1 isoforms dictates their subcellular localization and function.
  • This study establishes a mechanistic link between RTK signaling, phosphoinositide microdomains, and Arf6-mediated cell migration in cancer.

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.2K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.6K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
485
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
325
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
559
Gas Exchange and Transport01:20

Gas Exchange and Transport

Gas exchange, the intake of molecular oxygen (O2) from the environment and the outflow of carbon dioxide (CO2) into the environment, is necessary for cellular function. Gas exchange during respiration occurs largely via the movement of gas molecules along pressure gradients. Gas travels from areas of higher partial pressure to areas of lower partial pressure. In mammals, gas exchange occurs in the alveoli of the lungs, which are adjacent to capillaries and share a membrane with them.
76.9K